Yeramian Patrick D has filed 28 insider transactions across 1 company since January 2023.
Most recent transaction: a sale of 2812 shares of Amylyx Pharmaceuticals, Inc. ($AMLX) on January 09, 2024.
Activity breakdown: 0 open-market purchases and 10 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 9, 2024 | Amylyx Pharmaceuticals, Inc. | $AMLX | Yeramian Patrick D | Chief Medical Officer | S | Common Stock | 2812 | $16.33 | 205,605.0000 | 0 | 1.35% | 0.00% |
| May 15, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | Yeramian Patrick D | Chief Medical Officer | M | Common Stock | 2201 | $0.37 | 210,618.0000 | 0 | 1.06% | 0.00% |
| May 15, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | Yeramian Patrick D | Chief Medical Officer | M | Common Stock | 9764 | $6.88 | 220,382.0000 | 0 | 4.64% | 0.00% |
| May 15, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | Yeramian Patrick D | Chief Medical Officer | S | Common Stock | 11965 | $29.03 | 208,417.0000 | 0 | 5.43% | 0.00% |
| May 15, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | Yeramian Patrick D | Chief Medical Officer | M | Stock Option (right to buy) | 2201 | $0.00 | 15,404.0000 | 0 | 12.50% | 0.00% |
| May 15, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | Yeramian Patrick D | Chief Medical Officer | M | Stock Option (right to buy) | 9764 | $0.00 | 33,770.0000 | 0 | 22.43% | 0.00% |
| April 17, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | Yeramian Patrick D | Chief Medical Officer | M | Common Stock | 44861 | $0.37 | 253,278.0000 | 0 | 21.52% | 0.00% |
| April 17, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | Yeramian Patrick D | Chief Medical Officer | M | Common Stock | 4718 | $6.88 | 257,996.0000 | 0 | 1.86% | 0.00% |
| April 17, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | Yeramian Patrick D | Chief Medical Officer | S | Common Stock | 49279 | $30.53 | 208,717.0000 | 0 | 19.10% | 0.00% |
| April 17, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | Yeramian Patrick D | Chief Medical Officer | S | Common Stock | 300 | $30.94 | 208,417.0000 | 0 | 0.14% | 0.00% |
| April 17, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | Yeramian Patrick D | Chief Medical Officer | M | Stock Option (right to buy) | 44861 | $0.00 | 17,605.0000 | 0 | 71.82% | 0.00% |
| April 17, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | Yeramian Patrick D | Chief Medical Officer | M | Stock Option (right to buy) | 4718 | $0.00 | 43,534.0000 | 0 | 9.78% | 0.00% |
| March 16, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | Yeramian Patrick D | Chief Medical Officer | M | Common Stock | 2789 | $0.33 | 207,088.0000 | 0 | 1.37% | 0.00% |
| March 16, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | Yeramian Patrick D | Chief Medical Officer | S | Common Stock | 2416 | $32.43 | 199,250.0000 | 0 | 1.20% | 0.00% |
| March 16, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | Yeramian Patrick D | Chief Medical Officer | A | Common Stock | 9167 | $0.00 | 208,417.0000 | 0 | 4.60% | 0.00% |
| March 16, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | Yeramian Patrick D | Chief Medical Officer | A | Stock Option (right to buy) | 41250 | $0.00 | 41,250.0000 | 0 | 9999.99% | 0.00% |
| March 16, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | Yeramian Patrick D | Chief Medical Officer | M | Stock Option (right to buy) | 2789 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 16, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | Yeramian Patrick D | Chief Medical Officer | M | Stock Option (right to buy) | 30041 | $0.00 | 62,466.0000 | 0 | 32.47% | 0.00% |
| March 16, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | Yeramian Patrick D | Chief Medical Officer | M | Stock Option (right to buy) | 16748 | $0.00 | 48,252.0000 | 0 | 25.77% | 0.00% |
| March 16, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | Yeramian Patrick D | Chief Medical Officer | M | Common Stock | 30041 | $0.37 | 237,129.0000 | 0 | 14.51% | 0.00% |
| March 16, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | Yeramian Patrick D | Chief Medical Officer | M | Common Stock | 16748 | $6.88 | 253,877.0000 | 0 | 7.06% | 0.00% |
| March 16, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | Yeramian Patrick D | Chief Medical Officer | S | Common Stock | 52211 | $31.85 | 201,666.0000 | 0 | 20.57% | 0.00% |
| March 16, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | Yeramian Patrick D | Chief Medical Officer | A | Stock Option (right to buy) | 41250 | $0.00 | 41,250.0000 | 0 | 9999.99% | 0.00% |
| March 16, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | Yeramian Patrick D | Chief Medical Officer | S | Common Stock | 52211 | $31.85 | 152,088.0000 | 0 | 25.56% | 0.00% |
| March 16, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | Yeramian Patrick D | Chief Medical Officer | S | Common Stock | 2416 | $32.43 | 149,672.0000 | 0 | 1.59% | 0.00% |
| March 16, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | Yeramian Patrick D | Chief Medical Officer | A | Common Stock | 9167 | $0.00 | 158,839.0000 | 0 | 6.12% | 0.00% |
| Jan. 6, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | Yeramian Patrick D | Chief Medical Officer | S | Common Stock | 629 | $36.79 | 204,299.0000 | 0 | 0.31% | 0.00% |
| Jan. 6, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | Yeramian Patrick D | Chief Medical Officer | S | Common Stock | 1405 | $36.08 | 204,928.0000 | 0 | 0.69% | 0.00% |